Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 7/20 | 0.55 |
| ▸ | CYP4Z1 | Q86W10 | 5/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27714321 | 0.98 | SLC9A1 (0.56) | SLC9A1CYP4Z1ASAH1KEAP1HCAR3 | |
| SCHEMBL15165686 | 0.89 | SLC9A1 (0.51) | SLC9A1CYP4Z1KEAP1HCAR3APAF1 | |
| SCHEMBL24421779 | 0.89 | SLC9A1 (0.51) | SLC9A1CYP4Z1KEAP1HCAR3APAF1 | |
| SCHEMBL17365337 | 0.89 | SLC9A1 (0.51) | SLC9A1CYP4Z1KEAP1HCAR3APAF1 | |
| SCHEMBL21311179 | 0.85 | SLC9A1 (0.57) | SLC9A1CYP4Z1ASAH1KEAP1MGAM | |
| SCHEMBL25849028 | 0.85 | SLC9A1 (0.57) | SLC9A1CYP4Z1ASAH1KEAP1MGAM | |
| Bromide SCHEMBL28866483 | 0.84 | SLC9A1 (0.54) | SLC9A1CYP4Z1ASAH1KEAP1HCAR3 | |
| Bromide SCHEMBL28257701 | 0.82 | SLC9A1 (0.52) | SLC9A1CYP4Z1ASAH1KEAP1HCAR3 | |
| SCHEMBL31066856 | 0.82 | SLC9A1 (0.55) | SLC9A1CYP4Z1ASAH1KEAP1POLB | |
| SCHEMBL25613143 | 0.82 | SLC9A1 (0.55) | SLC9A1CYP4Z1ASAH1KEAP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354344-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354344-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | DNPEP, NPEPPS, PAM | SLC9A1 4880/4885CYP4Z1 2987/4885ASAH1 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.